J9361 Injection, efbemalenograstim alfa-
Also known as: efbemalenograstim alfa, Imankalimab
Injection of efbemalenograstim alfa, a granulocyte-macrophage colony-stimulating factor analog. Used for chemotherapy-induced neutropenia.
In Plain Language
white blood cell booster injection; infection prevention
Clinical Context
Used to reduce the incidence and severity of neutropenia in cancer patients undergoing chemotherapy. Stimulates myeloid progenitor cells.
RVU Information
CPT J9361 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9361?
CPT J9361 (Injection, efbemalenograstim alfa-) is a J Codes (Drugs) code. Injection of efbemalenograstim alfa, a granulocyte-macrophage colony-stimulating factor analog. Used for chemotherapy-induced neutropenia.
How is J9361 administered?
CPT J9361 is administered by a healthcare provider, typically via injection or infusion. Used to reduce the incidence and severity of neutropenia in cancer patients undergoing chemotherapy. Stimulates myeloid progenitor cells. It is used by Oncology, Hematology, Internal Medicine.
When is CPT J9361 used?
Used to reduce the incidence and severity of neutropenia in cancer patients undergoing chemotherapy. Stimulates myeloid progenitor cells.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.